Journal decision profile

Clinical & Translational Metabolism

Medicine · Biochemistry, Genetics and Molecular Biology

Clinical & Translational Metabolism's 2026 Journal Metrics Score is 1.2, ranking Q3 in Orthopedics and Sports Medicine and 3 other subfields. Two-year citation average from OpenAlex data, updated August 2026.

pISSN 2948-2437eISSN 2948-2445
Checking system sharing availability.

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
1.2

Journal Metrics Score 2026 · 2021–2024 window citedness 0.00.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED

Not available — there are not enough recent PubMed records with both received and accepted dates.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$4,790

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit Clinical & Translational Metabolism?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
1.22026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#1345 / 1,965LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
13.3%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
0.27MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
—NOT AVAILABLE
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
4 / yr2021–2024 AVG
Field-normalized top 10% share13.3%

2 of 15 works · same type, year & subfield

Field-normalized top 1% share0%

0 works · same type, year & subfield

Median FWCI0.27×

Below field-year expectation

Source output rank#1345

of 1,965 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.27, so its typical recent paper runs about 73% below its field benchmark.

What does Top 10% Share mean?

13.3% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2023–2025

12023
142024
152025

Recent work-type mix

15 OpenAlex works · 2021–2024

Article100%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and research coverage

OpenAlex topics show the research communities this journal serves.

Leading OpenAlex topics

2021–2024 works
Bone health and osteoporosis research2
Natural Compounds in Disease Treatment2
Parathyroid Disorders and Treatments2
Trace Elements in Health2
Chronic Kidney Disease and Diabetes1
Developmental Biology and Gene Regulation1
DNA Repair Mechanisms1
Health and Medical Research Impacts1
Metabolomics and Mass Spectrometry Studies1
Sleep and related disorders1
Methodology: OpenAlex snapshot 2026-10-28. FWCI, percentile badges, topics, and type mix use 15 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Orthopedics and Sports MedicineQ3
OncologyQ3
Cardiology and Cardiovascular MedicineQ3
RheumatologyQ3

Is Clinical & Translational Metabolism a good journal?

A mid-ranked Q3 journal by citation data

By citation data, Clinical & Translational Metabolism is a mid-ranked journal: it is Q3 in Orthopedics and Sports Medicine and 3 other subfields, the third quarter of journals by score, below the subfield median, and ranks #3,973 of 6,272 Medicine journals by Journal Metrics Score (top 64%). Clinical & Translational Metabolism's 2026 Journal Metrics Score is 1.2. OpenAlex lists an indicative article processing charge of $4,790 USD. OpenAlex classifies its papers in subfields including Orthopedics and Sports Medicine, Oncology, and Cardiology and Cardiovascular Medicine, so check that your topic fits its scope.

Best quartile
Q3
Orthopedics and Sports Medicine
Rank in Medicine
#3,973 of 6,272
Top 64%
2026 Journal Metrics Score
1.2
Acceptance rate
Not published
By the journal or publisher
Indicative APC
$4,790
OpenAlex, verify with the journal
Papers published in 2025
15
OpenAlex works

Check before you submit

  • Confirm the current article processing charge, waivers, and any institutional agreement on the journal website; the OpenAlex figure is indicative.
  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q3
Subfield Quartile
B4
CAS Block

Ranking and source check

#3,973
of 6,272 Medicine field journals
#344
among Q3 Medicine journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
45
H-Index
4
Fully Open Access
No
Recent OA Works
13
Subject Areas
Orthopedics and Sports MedicineOncologyCardiology and Cardiovascular MedicineRheumatology

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to Clinical & Translational Metabolism

  1. 1

    Check the scope

    OpenAlex classifies Clinical & Translational Metabolism's papers in subfields including Orthopedics and Sports Medicine, Oncology, and Cardiology and Cardiovascular Medicine. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

  3. 3

    Submit online

    Use the submit link in Clinical & Translational Metabolism's author guidelines. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.

  4. 4

    Plan for costs

    OpenAlex lists an indicative article processing charge of $4,790 USD. Check the current fee, waivers, and any institutional agreement on the journal website.

  5. 5

    Know what to expect

    Clinical & Translational Metabolism does not publish an acceptance rate.

Reviewer Two · coming soon

Know what reviewers will say before you submit to Clinical & Translational Metabolism

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about Clinical & Translational Metabolism

Is Clinical & Translational Metabolism a good journal?

By citation data, Clinical & Translational Metabolism is a mid-ranked journal: it is Q3 in Orthopedics and Sports Medicine and 3 other subfields, the third quarter of journals by score, below the subfield median, and ranks #3,973 of 6,272 Medicine journals by Journal Metrics Score (top 64%). Clinical & Translational Metabolism's 2026 Journal Metrics Score is 1.2. OpenAlex lists an indicative article processing charge of $4,790 USD. OpenAlex classifies its papers in subfields including Orthopedics and Sports Medicine, Oncology, and Cardiology and Cardiovascular Medicine, so check that your topic fits its scope.

What is Clinical & Translational Metabolism's Journal Metrics Score in 2026?

Clinical & Translational Metabolism's 2026 Journal Metrics Score is 1.2, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of Clinical & Translational Metabolism?

We have not found an official acceptance rate published by Clinical & Translational Metabolism or its publisher, and Journal Metrics does not estimate one because submission counts are not public. To judge selectivity, compare Clinical & Translational Metabolism's quartile and score with similar journals, or ask the editorial office.

What quartile is Clinical & Translational Metabolism in?

Clinical & Translational Metabolism's best quartile is Q3. By OpenAlex subfield: Q3 in Orthopedics and Sports Medicine; Q3 in Oncology; Q3 in Cardiology and Cardiovascular Medicine; Q3 in Rheumatology. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Clinical & Translational Metabolism will not match this score exactly. Compare journals using one source at a time.

How much does it cost to publish in Clinical & Translational Metabolism?

OpenAlex lists an indicative article processing charge of $4,790 USD for Clinical & Translational Metabolism. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to Clinical & Translational Metabolism?

Comparable journals include Current Osteoporosis Reports, Calcified Tissue International, Jbmr Plus, and Bone Reports. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to Clinical & Translational Metabolism?

Submit online through the link in Clinical & Translational Metabolism's author guidelines. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter.

Cite an article from this journal
Back to Search